NCT05523362View on ClinicalTrials.gov

Feasibility and Clinical Utility of the Dexcom G6 Continuous Glucose Monitoring Device for Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

January 15, 2022

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2023

Conditions
Type 2 Diabetes
Interventions
DEVICE

Dexcom continuous glucose monitor

The investigational device used in this study is the Dexcom G6 Pro/Personal Continuous Blood Glucose Monitoring system.

Trial Locations (1)

44106

University Hospitals Cleveland Medical Center, Cleveland

All Listed Sponsors
collaborator

DexCom, Inc.

INDUSTRY

lead

Ian J. Neeland, MD

OTHER